These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10802271)

  • 1. Low-dose oral contraceptives and bone mineral density: an evidence-based analysis.
    Kuohung W; Borgatta L; Stubblefield P
    Contraception; 2000 Feb; 61(2):77-82. PubMed ID: 10802271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-sparing properties of oral contraceptives.
    DeCherney A
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):15-20. PubMed ID: 8571999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the pill affect bone mineral density?
    Contracept Technol Update; 2000 Aug; 21(8):95-6. PubMed ID: 12349761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mass and long-term monophasic oral contraceptive treatment in young women.
    Polatti F; Perotti F; Filippa N; Gallina D; Nappi RE
    Contraception; 1995 Apr; 51(4):221-4. PubMed ID: 7796586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive health benefits: perception versus reality.
    Kaunitz AM
    Contraception; 1999 Jan; 59(1 Suppl):29S-33S. PubMed ID: 10342094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation.
    Scholes D; Hubbard RA; Ichikawa LE; LaCroix AZ; Spangler L; Beasley JM; Reed S; Ott SM
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1380-7. PubMed ID: 21752879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraception in older woman.
    Volpe A; Silferi M; Genazzani AD; Genazzani AR
    Contraception; 1993 Mar; 47(3):229-39. PubMed ID: 8462314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density and history of oral contraceptive use.
    Fortney JA; Feldblum PJ; Talmage RV; Zhang J; Godwin SE
    J Reprod Med; 1994 Feb; 39(2):105-9. PubMed ID: 8169923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
    Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hormonal contraceptives on microbial flora of gingival sulcus.
    Klinger G; Eick S; Klinger G; Pfister W; Gräser T; Moore C; Oettel M
    Contraception; 1998 Jun; 57(6):381-4. PubMed ID: 9693397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
    Jain JK; Ota F; Mishell DR
    Contraception; 2000 Mar; 61(3):195-8. PubMed ID: 10827333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hormonal oral contraception on acquisition of peak bone mineral density of adolescents and young women.
    Ziglar S; Hunter TS
    J Pharm Pract; 2012 Jun; 25(3):331-40. PubMed ID: 22572223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives for the prevention of osteoporosis.
    Corson SL
    J Reprod Med; 1993 Dec; 38(12 Suppl):1015-20. PubMed ID: 8120858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months.
    Hergenroeder AC; Smith EO; Shypailo R; Jones LA; Klish WJ; Ellis K
    Am J Obstet Gynecol; 1997 May; 176(5):1017-25. PubMed ID: 9166162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.